<SUBMISSION>
<ACCESSION-NUMBER>0001193125-06-078555
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20060406
<ITEMS>1.01
<ITEMS>5.02
<ITEMS>9.01
<FILING-DATE>20060412
<DATE-OF-FILING-DATE-CHANGE>20060412
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>AtriCure, Inc.
<CIK>0001323885
<ASSIGNED-SIC>3841
<IRS-NUMBER>341940305
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-51470
<FILM-NUMBER>06755477
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
<PHONE>513-755-4107
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>6033 SCHUMACHER PARK DRIVE
<CITY>WEST CHESTER
<STATE>OH
<ZIP>45069
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML><HEAD>
<TITLE>Current Report</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:3px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(d) of the </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Date of Report (Date of earliest event reported): April&nbsp;6, 2006 </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>AtriCure, Inc. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR
WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-51470</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>34-1940305</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>6033 Schumacher Park Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>West Chester, OH</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>45069</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: (513)&nbsp;755-4100 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or
former address, if changed since last report) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;1.01 Entry into a Material Definitive Agreement. </B></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">In consultation with the Compensation Committee, our Board of Directors approved changes on April&nbsp;6, 2006 to the compensation given to our
non-employee directors, effective immediately. Directors will now receive an annual retainer of $20,000, with additional fees of $25,000 to the Chairman of the Board, $10,000 to the Chair of the Audit Committee, $5,000 to the Chair of the
Compensation Committee and $5,000 to the Chair of the Nominating and Corporate Governance Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">In addition, the initial stock option
grant to non-employee directors upon joining our Board was increased from 20,000 shares to 50,000 shares, which vests one-fourth on each anniversary of the date of the grant. The annual stock option grant after each Annual Meeting of Stockholders to
each of our non-employee directors who has been a director for at least six months was increased from 3,000 shares to 10,000 shares, which vests one-third on the earlier of each anniversary of the date of the grant or the Annual Meeting of
Stockholders that year. In light of the change in initial stock option grants, the Board approved stock option grants for 30,000 shares to the non-employee directors who will stand for re-election at the Annual Meeting of Stockholders, which vest
one-fourth on each anniversary of the date of grant. Vesting of the options described in this paragraph are subject to continued service as a director. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Non-employee directors also receive a fee for each Board meeting of $1,500 for in-person attendance and $500 for participation by telephone and a fee for each Committee meeting of $750 for in-person attendance and
$350 for participation by telephone. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal
Officers. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On April&nbsp;6, 2006, our Board of Directors appointed Gene R. McGrevin to the Board and the Compensation Committee and he
will receive director compensation described above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">A press release announcing the appointment was issued on April&nbsp;12, 2006, a copy
of which is being filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01. Financial Statements
and Exhibits. </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Exhibits. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release dated April 12, 2006.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">ATRICURE, INC.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ David J. Drachman</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">David J. Drachman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dated: April&nbsp;12, 2006 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT LIST </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press release dated April 12, 2006.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g72135img001.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2">Contacts: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>AtriCure, Inc.</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Thomas Etergino</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Chief Financial Officer</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">513-755-4561</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">tetergino@atricure.com</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B><I>The Ruth Group</I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Stephanie Carrington / Nick
Laudico (investors)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7017 / 7030</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">scarrington@theruthgroup.com</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">nlaudico@theruthgroup.com</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Jason Rando (media)</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(646) 536-7025</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">jrando@theruthgroup.com</FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>Press Release </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>AtriCure Appoints Gene R. McGrevin to its Board of Directors </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>WEST CHESTER, Ohio, April&nbsp;12, 2006 </B>&#151;
AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative surgical devices, announced today the appointment of Gene R. McGrevin to the Company&#146;s Board of Directors. Mr.&nbsp;McGrevin
will serve on AtriCure&#146;s Compensation Committee. The appointment brings AtriCure&#146;s Board to 10 members, eight of whom are independent. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Mr.&nbsp;McGrevin, 63, has over 30 years of senior management experience across the medical device and diagnostic pharmacy service industries. Most recently, he was Chairman of the Board at Microtek Medical Holdings, Inc., a medical product
and supply company, where he was responsible for leading the strategic direction of the company toward double-digit revenue and earnings growth. As Chief Executive Officer of pharmacy distribution company Syncor International, he led the expansion
of a domestic and international distribution network that helped improve Syncor&#146;s market share from 50% to 70%. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Currently, Mr.&nbsp;McGrevin serves
as Chairman of the Executive Committee at Hydro Dynamics, Inc., a company focused on researching and developing liquid-based power solutions for the manufacturing sector. He has also held senior management positions at Johnson&nbsp;&amp; Johnson and
Kimberly-Clark Corporation. Mr.&nbsp;McGrevin received a BA in Economics and Political Science from the University of Pittsburgh and an MBA in Marketing and International Business from the Wharton Graduate School. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Richard M. Johnston, AtriCure&#146;s Chairman of the Board of Directors, said, &#147;We are pleased to welcome Gene to the Board of Directors. His breadth of experience
in the healthcare industry includes strategic, operational and financial management, new product positioning and building successful strategic alliances. We believe he will add immediate value to the Board and we look forward to his
contributions.&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"><U>About AtriCure, Inc. </U></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft and
cardiac tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably
create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a rapid, irregular quivering of the upper chambers of the heart. Atrial fibrillation affects more than 2.4&nbsp;million people in
the U.S. and predisposes them to a three to five fold increased risk of stroke. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This press release contains &#147;forward-looking statements&#148; within
the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such
as earnings estimates, other predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure&#146;s products. Forward-looking statements are based on AtriCure&#146;s experience and perception of current
conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure&#146;s control. These risks and
uncertainties include the rate and degree of market acceptance of AtriCure&#146;s products, AtriCure&#146;s ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals
for its products, the timing of and ability to obtain reimbursement of procedures utilizing AtriCure&#146;s products, competition from existing and new products and procedures or AtriCure&#146;s ability to effectively react to other risks and
uncertainties described from time to time in AtriCure&#146;s SEC filings, such as fluctuation of quarterly financial results, reliance on third party manufacturers and suppliers, litigation or other proceedings, government regulation and stock price
volatility. AtriCure does not guarantee any forward-looking statement, and actual results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward-looking statement, whether as a result of new
information, future events or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"># # # </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g72135img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g72135img001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`30#]`P$1``(1`0,1`?_$`,L```$$`@,!````````
M```````'"`D*!08!`P0"`0$``00#`0```````````````@$#!P@%!@D$$```
M!0,"!`,%`P4)"!,````!`@,$!1$&!P`((1(3"3%!%%$B%18783(C<8&T&`KP
MD:%"4B1T=AFQP=%3-"4U./%B<H(S8W/#5*35-F8G-T>7*%D1``$#`P,"!`0$
M`P8""P````$``@,1!`4A$@8Q!T%1$PAA(C(4<9$5%D)B(X&Q4H+2%[)6H7*2
MHC-SDR14E!C_V@`,`P$``A$#$0`_`+_&B(T1&B)F^[S=`]V\0]LM[:BX>;N^
MYWBYV[.;,[%@SAF)?YX_608N&CE8QW!R)$HJ4"F-4:TIJ;&[NO11<:)5]O&9
M6N=<80]])M$8Z145<1D]&-U3*HL9EB)`=)H&4$51;*%4*=/FJ/*:E1I48N%#
M15!J$N.J*J-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB
M-$1HB-$1HB-$1HB-$1HB-$5=G>?DPV2L]70HW7!:%M`0M"(*0QA2$L8H<))P
M0#&H0[F1.<IZ4KT@U]#!1M%;)J4X?MLY-&(O:Z<6OEP*SNM@%P0R9S<`F8<A
M4WB28F&A`7CCB:@4$YB!P&FHR:ZJK3X*9_5E31HB-$1HB-$1HB-$1HB-$1HB
M-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$2.Y^R(WQ9B&^;
MS54(1S'PCI"*(<PE%>9?D,SC$"&#P4.Z5`0K0.&JM%314)H%#!LMPC&YUR9/
M.KZ9K2UJP,.\D)D3+.&WQ*=F%!19D%TV,0X.$UE3N1*)@`P!Q#RU?D.T:=5!
MHJDKD6\OMJW$'!,3HKX[ODCIJ(B<P/(`'95D!-6@N4UX=:AO$#G`>&I4#F?V
M*G0JR!!3+&XH6)GHQ4%H^9C64HR5`0$#M7[=-RB(B41#F!-0*AY#PU\I%-%=
M65T1&B+CF+S<O,',`5$M0Y@#PK3QI71%SHB-$1HB-$3&]R.]:&P+>+&QF-H*
MW?-BQ:2LR898D4UC&3PZ@-D$S`R>G</5TTC&H($*0*"-:TU<:S<*GHHN=0T"
M=!BC),+ERP;>O^`2<MF$^TZ_HG8%]4Q<IG%)RS7,2J9SH*E$`,7@8M!X>`0(
MVFA4@:I0QU1*T23YCSIB+;[:#F^\S7_;F/;7;B<A9&X'Q&YWSDB9E?01+$G4
MD)>14(4>1NV256-Y%US."X[G.37HQV"MI;F[/\+&UVBM*N=]+6CQ<X@?%==Y
M/RWC?#,8[+\GO(+.P;7YI'4+C2NUC=7/=Y-:"3Y*$;)W[0]MUM]^\C\48?R=
ME(C195(LN^6C+*AWQ2B8$W#(54Y^6!NL``(==H@H`#Q(`AK8+$^V'D]S$V3,
MW]I9EP^EH=*YOP=38VO_`%7$?%:J9[WI<*LIW0<>QM]?AI(WN<R!CJ>+:^H^
MA^+`?@DN@/VC^S5'($O+:K=\`T$Y0Z\-D6-G5@3$M3&!!_:=ND,<#<`+U*"'
MF&N8N?:O?!E;',P2R"NCH','YMDD_N77[3WOXLR4R7'[B*.O6.Y;(:?@Z&+^
M_P#M4K.S?N9[:=[<J_M7%KRZX6^XJ(/.R%E7G`#'2:44BLBV7>H2$<YE8%TB
MDX6*7E*ZZH@->0`UAGG?:;EO;^%MYF&PR8Y\FP2Q/W-+B"0"'!KP:#J6T\*K
M8?MEWVX+W5N'X_`.N8LM'&7NAGCVNV`@%P<TOC(!(Z/KK6BD)#[=8R69ESHB
M-$1HB-$1HB-$1HB-$1HB-$1HB-$1HBB8[F&3`(E96)V2X?B'->$^0A@]U)'J
MLX=NN6M0YUA46+Y#T_'5Z(#J>B@X^"<IL0QB./L&1<L\;]":O]R-TON9,4UR
M,5"="&;+@)0-5%H43AQ$**AJ#S5U/!5;T33NY9B\&<S:.6F#<`0E4!M.XCD+
M6KQJ55W#N5?`I2F;BJE7Q,;E"O"FIQ./14>$Y?M^9-^=L*DM9ZXZLOCF0-!&
M*<U530SDHO(A4PF$5%1*4RA!-Q`.4`U&04-1T56G1/LK^[]W#5M22([C,C36
M*</7A?-NHLEYJ'9IBP"03.LT37<+D;E651(=,5>CU.8"U`!$`KPX:DT`FA5"
M:!,H[?%]79D:[<QW5>DV]GIM^2",JZ=J5(DF!EA3;-&Y1!%FT1`:$23*4A0\
MM3D`;0!4::J4;5I21HBXK[./Y/:'E^71%SHB:)GW9SC_`#W<;"[I26FK<N!N
MS0C'SR(],J23CFQSF;IKH.DSE3<-P5,!%"C2@\2C34VO+1314(JG"8[L*W,8
M69!6/:B"B,'`,RM&@KJ`NZ<&YA,LZ>+E*0%G3A4PF.:@<1H````&H$ZU*4H$
MGFYC<)8^US"=\YMR`X`D'9T4HX;L"*D2=S\XX`482W8X5.!GTP_$B1.`\H")
MJ#2FNQ\2XQDN8\@MN/XQO_N)WT)ZAC!J][J>#6ZG\EU'G?,\3V_XM=\JS+J6
MMM'4-J`9)#I'&VO\3W4`\NO@JFFW7$V>.]GNEN7*6=KFE83!^/W;<TPQAU52
MQ5OQ3I<[B%QC8R)P](VF'S.JCR143,L9,IE3<QA(0NZ7*<UQSL!PZ+#\=A9)
MR"Y!V%U"Y[@*/N)O$M!T:P:`T:-*E>=7"N.<O]U/<"?D/+;B2'B=F\;VL)#(
MV%Q++6`=`]P^N0C=0%QJ2T"V9A7;%@/;S;+*T\/XLL^S(YDU3:G=L(9FI.R8
M$*4#.)NX'"2TQ,.U1"IU'"RAA'V!0`TMS_+^2\HNW7N=O)YY'.K0N.QOP8P'
M:T#R:`O17BW`N'\+L&8[C6/MK6%C0-S6-,COB^0@O>X^)<XK9<BX.PWEN(<P
M63,76'?,6Z;J-E&URVM#2IB)J$.G5LX=-#N&:Q"G'D42.0Z8\2B`\=?'B^0Y
MW!SMN<1>7-O,#4&.1S?S`(!'F""#XA??FN)\8Y';.M,[C[.[@<*$2Q,?^1+2
M01X$$$>"AFP9L<M78]W2K0>8E+*-<.YYPUE!2*@G2ZL@2TKFM@T5(R%NED7)
MC.W$4JU4!PSZIE%4Z&(8YO='6>.1=PKSN'V>G;FRQV?QU_!N>!M,D<FYH?M&
M@=7Y74`!T(`U6K_$^U&/[4>X&U?QSU&\8R^,N]D9)<(I8MCG1;CJ64^9FZI&
MH).BGK]M/X?/^_K6^JW`04Y3UY3%-01`>40&@@-!`:"/$!\=5U&AZJ@(/1<B
M--#T55\F.4HE*)B@)J@4!&@FH%1Y0\34#V:>"I4=/%?5?]G[=4"JO@ZR1#$(
M=1,AU1Y4BG.4IE#``"()E$0$XA]FI`$BH!H%$N:T@.(!/3X_@@ZA$@YE3D3+
MX<QS`0/WS"`5U0!QT:*E5+@W5Q`"Y`U0J`@("%0$!J`@(>-0'B`Z=.JKIU\$
M'4(F43J&*F0OWCG,4I0#VB8P@`!H*DT&I5'$-%7$`+2%,GXX2E4X)6_K,3FE
M@.*44>YH8L@H"1P24$C07@+FZ:A@*-"\!&FN0&(RSH?N&VTY@'\7IOV_G2BX
MDY_!"Y%FZ\M1=&M&>JS<::=-U>NBW<ARJ%`Y#$.0P5*8A@,4P>T#!4!#7'FH
M-#4%<N"TBK34+Z_>T3Q7.B+J772;(K.5U"I(-TE%EE3\")I)$,HHH<?(I"%$
M1T15Y+A7?[I-V*K9L91>/N2]4HIH80ZJ;.SH%STE%0IS?S0S)NHK7RZU?LU]
M`^5BMG4JPI'L&L6P8QC%(J#*.9MF#-`OW46K-$C=ND7[$TDP`/R:^=7$CFXS
M&J&6,.7K9YDRG?+1:LE"&,%>C.1)3/8Q0H``B)NNERT"E>;4FNVN!5"*A0Z;
M$\C*XYSTSM^5.=G'7TW6M"2;K>Z#>926ZT6*A#"!$5$WZ)DCF&@@`B%?+5Z0
M`BH4&]=5//,M';^(E&,>\&.?O(YZU9R`$,<S%TX;*HH/"D*=,QC-U#@<``P"
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MMM[6?K-I`[A,[0R@.))ZR,B*-`,BY`QBCQ'1H:16FJH2:T\%)CMG55<8#Q4N
MX54776M)@JLNNH959910ZIE%%53B)U%#F$1$1$1$?'5I_P!14V]%7;_:,\TR
M22^!L`,'2B<2Y;S64;B1164(#ITT6&`@VKU(#@FND@559=,#%$"G`#>--;@^
MUK`1$9+DL@_K`LMV$@:`_.\@TJ*Z`T/1:`>]KE%PTXCA\#B+9P?<R`$BKJF.
M,.'B`-Q%>A.FO25SL_8<B<0[#,-BT9)MIG(\>YR5<RP)`5PXE+C7-T"++&_$
M43;1S5$J91]T@"(%``$:X9[XYR7.=Q[\.<3;VKA!&/`-8-:#PJXDE;#>VKC5
MOQSM%C'1MVW-\PW,AI\Q=(:-!/C1C6@>6JD\IK$:STC1%YU&K959!RHW04<M
M@5!LX.BF=9N"Q0(L""IBBHEUB!0W*(<P>.JAS@TM!(8:5%=#3S\U`QQN>)'-
M!>VM#345ZT/A7QHJS'>OW,;R=L-^6E$8WW'RL#CO,$-/.F]J6Y9]N0$O:J4,
MNS:]!O>Y47MS.EG0KF.*Z2S,Q!X`7SUMIV!XEP3E^,FN,IBHY,I8R,!D?*][
M9"X$U,.D8`H!0AU5H?[J>=]SN`Y:WML'G)(<-DHI"(8H8HWQ!A:V@GHZ5Q-:
M[FN81Y*2[LZR\M<&PG$\W/2DC-S4J^NI])R\N]<R,G(O7$VNHN[?/G:BSETX
M6.-3'.8QA'Q'6)^^4$%MW(O8+9C(X&-C#6M`:UH#!0`#0`>`&BSO[9[BXN^T
M./NKN1\MS)),7/>XN<XF0U+G.)))\222G9[KXS*[_!=]/,-984PS>MMPLG=K
M:\$;/@[V6.UMJ,>R[B$"(N(31::<QZ8$3KF34.D41$A:ZZ7PR;#1\BMH\[9?
M?V$LC8S$97Q"LC@T/W,^;Y:U`!`)ZZ+(G<6#D4W$;R7B^1.+RL$3IA,(8YS2
M)KGF/9+\@#Z;2ZA+1J!556>U;NLW$;E^XSBN1S?EN\+_``0M#(3EG%RDB+>W
MF"YX+F%=A;4<1E`LEQ`U!.DV(:@`%:`&MQN\?#.,<2[6WD7'K*"V!FA!<UM7
MN&\:.D=5Y'P+EY^^W[N#S7G'>RREY9DKF]+(KC:U[J1M_INU;&W;&TGQ(:"K
M5&Z2W<NS^(KE/AC,:F%+J@XN7N`UT(V9!WLN[;1,2\>!$IL;A4]"R*[62*!G
M'354('W0KK3GA]S@[;-Q#/6'ZA9R/:ST_5?$`7.`W59J:#PJ`?%>@?<&RY+>
M<;G=Q?*'%9"&-\GJB".<D,8YVS;)\HJ1JZA(\%2;VZ]PO/=F[J([.&5+HO\`
MW`7K$0EZVU8MI2TX_?12U\W4U)!P2#*$3738Q46K(G#J)L$"*'"A"EJ:H;_<
MI[8\;ON'/X]AX;;&8Y\D4DTC6!KO1C.]Y+R"7.IT+W$#J2O*_A'>KF&+Y^SE
M7()[S,Y6.*:.WA?(YS3-*TL8&QU`8TN(JV-H)I0"JDTR5V\N\-O!8*Y-S%FF
MW+0>2J7Q&-PZ[R!<=NM8)NX(+AK'-;;M&.>6I'.FR:@)F%TY,[`0Y5E!,`TQ
M'BNYW8W@T@Q.#L)9V1G:ZY$+)"\C0N,DCFR.!Z_*W;_A`%%G?.]EO<OW*A.>
MY-E(;::0;VV1N9(FL!U#1%"QT+2!I\[R\='.K53*P&9UM@';QQS=VZHZI+XQ
MKCZ)MB:@6LVWFY6Z;Z3,[;1-O1,N+EV@_=RA4B&%<5#E22`QC?=Y=8*N<`WN
M7W/NK+AM/T^[NG2,>6%C8X="Y[FT!:&U.E-30>*V>M.4.[.=E[+(]P-WZM8V
M;8GQB0/?+.-P9&U^XAQ<`"75(`J3THH+,3QV_+O6WU>D_<&8)+!NVBV),\:Z
MC+<4DD+;2%T85V]K1L#&OHL]\SR$<<#.G<DX!%*ONB43`EK8G-R=M^P6.M[:
MVL69'EDS-P=)0R::&1SW!PB87?2UC:GXT)6I7'(.[WNGRMU=WN2DQ/!8'EA9
M'N$0KJ(FQM<SUY`VA<^5VT#RJ&IXDW^SI876MQ1"WMPF4&-W@@<$IB5C(61A
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MOIA@B['K5P*$W<J(6E!\AP*L5W-$.@NY3`?O@T9=0Y@]@:DT;BJ$T"9%VTL8
M>HF+ORP]1`4(IN6T[?,<HB/JW92+RSE`W$?PFQ2HF`?Y?#5R5VE`HL&J;YW#
M.]JCMDRI/8)P;8,/?E[6<=!K>UV74]=(VQ"32B17"EO,(J/%!]+/6:"A!<*B
MN@DF8X%+U!`PALEVP]O[N78>/D7(;F2VQ\]3%'&T&1S0:;W.-0T'7:-I)&IH
MM..]/NJ;P+D$O$N)V<5WE;8@333.<(F/I4QM8VCGN;IN=N:T'05H:+!VT^[I
M";V;J?8=R%9;/'686D,YG84(B15?VS>L=&%3-+_#2.B%?14I'IGZQFRAEB&0
M`3%5J`EUP7=CLE<=O[-N=Q=PZZP;I-CMS0V2)SC\NX@T<T]-P`-="/%=F[$^
MY&U[JW[N-YFU;9<D;$7LV.+HIVMU>&U&YCVBKMI+@6@D.J"$AV[ZP'>&MPTK
M*0J8LF4X_:W_`&RJ@`I)).5'8.7K9(Q1`>9O*)"8_A4%?/6#6$.;KT6SY!#J
MJ<_$-^M<G8TLV^6BA5/F""8NW8%`"BE)%2!&11,0/^"$CU,]"T`0+3VZ^<BA
MHK@-15(QO;_U;,A_T9A^G(:DSZD=T3.^V%_EF5?^1@_[JFI2>!46>*ESU:4U
M$WW/J>FQ37_I<Y^CIZO1:5=XJ#TN_;OA6<;M]0D44P]9.W5.O'J_3`IU00,W
M;-4S&#B<B"11`OY1U"3ZE5O1/M_?U!24$_<='_SZ9!_X%AQ_ZT__`(-7V?2K
M;NJE@VQ?ZOV)OZG1W_.ZLO\`J*F.BKP]\;9SN5SON(QO>>%L/7ODZ"3Q<>'D
MWMIPRTDA$232;<'*S>JICRD7<H.`4*4?$H:W`]O7.N)\=XM=X_/WUO:7/WFY
MHE=MW`L`J/,`BA\%H![K^V?.>6\UL<IQ?&7=_:"Q#'.AC+PQS9'?*XCH2""/
M@I]ME<'<UL[4,`6Y>5N2MHW3!8RMR(GK:G&YVDM#R,>V]*NT?-E`*9%8HI5H
M(>!@UK;S^XM+OFF3NK"5D]G)>2.9(PU:YKC4$'R6X7:RTOK#MUAK')P26V0A
ML(F212#:]CFBA:X>!T3H-=07?D:(N!U0HJWW?<VO;@]PMV;?WF$L17KDQM;E
MOW>UG5[3B%9-.*7>R#%5JD\,F-$CKIIF$H#X@&MJO;GR[C'&;+)LY!?6]H^6
M6(L$C@W<`UP-*]:56CONZX#S/FF1PTG%<;=W\<,$PD,+"X,)>T@.IH*@&GFI
M*NU-C'(&']D>*K"R=:4U9%Y0YYX9.W+@:'8RK$',HJLAZAL?WD^JD8!#VAK%
M'>7+XS.=P+S(XB>.XL'AFU[#5IHT`T(6=O;U@<SQOM788C/6TMIDXW2%T<C=
MKV[GDBH/2H3U<NQK^9Q1DZ'BVJS^4EL>WI&1K%N7G</9!_;<FU9M$">)UG+A
M4I"!YF$-=`PDL<&:LYYG!L++J)SB>@`D:23\`-5E+DD$UUQV_MK=I?<264[6
MM'5SG1.#0/B20!\54O[0^R;=IA?>UCR_<K8!R385FQUIWJTD+CN2`<,(MHY?
M0J:#-!=PH/*19RM[I0\QUNEWMY_PO/=O[G&X?)VES?OFB(9&\.<0'U)`\@O.
MOVW]K>XG&.ZUKF.08>_M,6V*<&66(L8"YA#02>A)-!XU5N'(;)W)V!?,:P;J
M.WTA9US,635$HG6<NW<*^0;MTB!Q,HLLH4I0#Q$=:3XN1D63MYI"!$R>,N)\
M`'`DG\`O1O-123X:[@A:73/MI6M`ZEQ8X`#XDF@5-[MX]N_=#;>^'#EY9DV[
M9&M?'EJ7E(74^G;DMI5*"3=1B3QQ#^N47'I=-1XH0Q.8!`3%#@.M[>Z'=#B%
MUV]OK#!92TFR<UN(PR.0%]'$!VVGPK7X+S&[*]EN?6/=?&Y3DV$OK?"V]T97
M/EB(C!8"6;B=*;J45U'V^=?ST^W\VM!.FJ]3/Q5<#OI8?W9;B;GPMCO"&',B
M9#QS:L1,7;/OK6@W#^,"\W[CX8R07<)"!%%6D,4P@0:\HJ5"@^.U'MVSG"N+
MVE_D^0WUM:Y2:1L;!(\!WI`;B0/"K_'X+1_W;<;[B\TOL9A.*8R]O<+;Q/ED
M,49<WUG':`7#2K6#I_,?[4`V:Y2[HFR_"4=A&R>WI<]QQ;*?G;B7G9B&N)M)
M/W\\NDNX%RFU'H_A`B4I1_D@`>6NS\\P_:#GO('\@O\`DT,4SHF,#&.86@,%
M!2NNM:FOBNF=LN1^X#M?Q5G%<9PNXGMVS22>H^.4.<9".H'E0`?`)U?]H%W=
M?_S9D_$.(QUU_P"'VZZ:.V79'_FMGYQK(/\`O/[DO^1I#_DF4<^_2`[DV_93
M'SN]M@UZ65*X]"608REN0$R\<OX^7Z1U8YT=^%2-TW*0*@!1H)O+64NW%SVH
M[;MN68_DMO/%<[26R/:`'-K\PIXT--5A3N]:]\^\!LY<KPZZM)[,/#7QQO<X
MM?0EIW>`(KHGP?3;>K_8G_0GZ.9%^LOS7],/I_\`"W/S9])_F+J>O]#R=;X?
MZ'A6M.EYTX:Q[^K\`_W_`/W)]]:?H'H^OZVX>G]QZ=-N[INKK^/Q66_T+NC_
M`/EG]I?IM[^YO7^V^WV'U?M/4K79UVT^7RVZ]-%9-UJFMXE"EW'<CJ7+DBV,
M812PN6UHL2/GK5(Y3D5N:>,9!JC[O%-RW8T()1_QX:OQ``;O%0<:Z*3K;?C9
M'%.&;(M/I`G($BD):<,!1(=:;EB$>/CJEJ(`JD8Y4A\OP]6GNJZJD!0:*D+W
M4MK.5,#;N,KSMQ6]./+&R?=\K>]C7H1D[=Q,RPFU1>N&"C](JZ*,K$N#'25;
MG/SE(4@TY1#7I)V<YCAN2<)LK>VEC;D+2!L,L1(#FE@H#0T.UPH0::ZA>//N
M&[>\AXCW&R%W=PRNQ-]</G@GH2Q[9';BW=J`YA-"VM1H>A3G.QEM9RG>NZJ!
MSV>WYF$Q7BR/G5']T/&JS%I,7%)1XLXVW8L[@J7Q`XBN*KGDYBII!QXB`:ZC
M[A^88?'\-DXWZD;\S>O92,$.+&-=5SW4^D:4;74E=]]I?;_D&5[@1<O?#+%@
M,>UY=*06M?(YA:V-M:;J[JNIH`->H5D;N)XN&[,4,;]CVG5EL>2(.7JB:8F6
M-;4E1"1*92M"(,W'37'_`'.M"XR`:'Q7J0X>/BD][:>30>0-X8H?KB+B%=_-
M,$F<>/PZ1,FUDD2&,-1!)Z0ABD#@4IA&@:K**G<J-\DY[>V/_P!;,A_T5C^G
M(^>HL^I5=T3.NV"-7F5O9T8*G[ZFI2=`HL\?Q4NFK2N*)ON??Y-BG^ESGZ.G
MJ]'T*@Y.GV+A3;99`?\`&2OZ:?4)/J56]$[W4%)03]QW_P!>V7]18?\`2G^K
MT?TJ#NJE@VQ!7;]B;^IT=_=4U:?]14F]%'[WF,:YPN+:_P#4_`&0<G65=^&Y
M8]SS[#&]YW/:KFY+'<-CM9\KU*W91@:1/!EY'B93%.8"D/3AK-G8C*\>M.7C
M$\EM;2XLKYGIL,\4<@9*#5E#(UVW?])/3I5:W^YW!\LO>`G/<-O+^UR6,D,L
MC;::6(R0$4DJ(WMW>GH\:$T#J)B?8\[BZ]W%G-K>?\B3T]?;V5=W/BF\;^N*
M0G7]R-G9$`EK,7N&<>O'JTFT5("[%%10"G1,<B=3@!1R-[A.UHL?3YAQJUCC
MQ[6".XBA8UC8R*[9=C``&GZ7D#0T)TU6(O:AWL?DFR\!YE>RRY=\ADM9KB1S
MW25IO@,DCBXO!^:-I.HW-;J`%9EKK4Q;W+G5":"J+Q/9%A'$14D7K1BFX<HL
MVYW;A)L5P\<")4&J`JG)UG"P@/(0M3&IP#5R.*68EL32Z@)-!70>.G@/$JU+
M/#``Z9[6!S@T5(%2>@%>I/@.JK1?M`N5LSXMN/;HYQCE#)>.(R6AKQ;RHV'?
M5SV@WDWZ#QBJW+()6_*1P/5D6XFY#*@;E*(@`A76V/MGP^`S%KE&9>SM+N=D
MD19ZT,<A:"UU=N]KJ"O6E%HI[RN1<IX_?863`7]]9020S!_V\\L(<X.93<(W
MMW$#I6M%)EV@K[N7(NQ'%5RWA=]PWQ<JKRYFDM<%TSLE<DVNX:2RA01?2TNY
M=OUS-TS%``.H;E+P#AK$O>_'6F+[BWEK8016]IMC+61L:Q@!;U#6@`5/P6>/
M;9EK[-]I;"_R5S-=WQDF#I)9'RO)#SHY[RYQH/`G1.FW?Y4986VPYSR4]D_A
M`VUC:Z5H]\1PHT<I3#R+<,(<&*R"B3DL@,BZ3%'I""@'`!+Q#73^#X>3/\NQ
MV)C9O]6[C!%*C:'!SJ@BE-H-:Z4ZKO\`W+Y!%Q?@.6SDC_3,%C*6N!(.]S2U
MFTBAW;R-M-:]%4\[-.X7<#?V_#'%L7_G7,E\6XZM&^UG=OWADZ]KE@W;AK"%
M.W7<Q,U-O6"ZK=7WDS&3$Q3<2T'6Y_??B_&L9VYNKO&XVQ@NFS0@/B@BC>`7
MZ@.:P'\==5YX^V/FW,<WW<M+'+Y;)W5BZ*<F.:ZGEC-(W$58][FZ'IIHKC^2
M7#AICJ_G;1=9JZ:V5=+ALY;*G0<-G"$&_517062,51%9)0H&*8H@8I@`0&NM
M%<2QDF4MF/`+'7$8((J""\`@CR7IEG9'Q82\EC);(VUF((-""(W$$$:@@ZU5
M.?M$9YSWDGN!6+:U^YWS5=]L%C<A2"MN7)E*]IR!=KQC!8[(KV(E9IY'NDD3
M#4"G3&@@%*4UO1WOX[QO%=M+B\QN-Q\%V70MWQV\3'@.<*T<U@<*_`KS-]MG
M+^7Y[O%:X_,9?*7-@&SN,<MW/)&2V-Q&YCY'-(!\"%=-$-:#T_->I"JQ]_6Z
M]QF(<MX9OO&V7,O6%CZ\+,DK?<M[&OZ[[2@BW=!R)W9TG#2!F6+1Q(.XAR"O
M.8G/R)TJ(!K</VV6/%LYA+_'96RL;G)P3AX,L,<CS&]M-"]I(:'"E`?%>?GO
M"R/-N-<AQN7P62R5IA[FU,9$%Q-#&)8W$D$1O:"YS7`UI6@^"D)[)6Z1SN!V
MHA:MXWG,W;E7$UQ2,'=#JZ9I].7(_@Y%7U]MS+F2EG+F3DDED%3I&5.<_(HG
MR":M`UC+W`<0CXSS/[RPMXX,+>Q-?&(V!C`]HVR-#6@-;0T--*@U69_:OW`?
MS/M[]AD[J2XY#CYW,E,KW22.8\[HWESR7.&I;6IH12JF3\=8*6S:!_=Y:H=$
M71ZIMT/4^H1]-X^HZR?0Y:\M>KS].G-P\?'4MLE=M#O\J:_DK?J1[-^X>GYU
M%/S6.N&<8VU`S-PR2I$6$)&/91VJH<$R%09-U'"E3FX%Y@3H'VCH!4T5Q0,;
M>X%YN1W7&NB;2.XC0N&0R'.E6`RA"1[!R4\+'./XP=0P((@(#XDU><0UJM@5
M-5/_`$_-Y\-6"*JXL;*PL//,E(V<BHV9CE3%,K'RS%K(LE#$&I#*-7B2R!S$
M'B`B7@.KL,\UM();=[V2C^)I+3^8H58N;6VO(C!>1QRP'JU[0YI_$.!"]#%@
MQC&B#"-9M8]BU3!)LR8MT6C1ND7[J:#9`B:*29?("E``U&222:0RS.<^5W4D
MDD_B3J5.*&*",0P-:R%HH&M```\@!0`+%W3;K"[+;G;8E$B+Q\_$OHEVFH0#
MD%%ZW40,82#P$2"?F#[0U`:=%<^"KWXCGWVVC<\S;S*JC=K;5UO[,N0YZU5@
M7ZX,3O%"")2\PM3HK@(\"5KPU]!`<P^:M:@J<#<#9B^4\'WY;,#TG[Z<ME=Q
M`&24*=)T]23*]8"B<IN10KGD`""`T-S!JRTT<KAU"A^V?9\@-MUXWE$Y.CI:
M)CYUJ@U<*%CUCR$1+QBXE,B[8F`K@Z!TQ$ON%,('#V:NO:7#16VG:I/\-;HV
M6=[^DH*Q[0G4K(@XE9X^O69;G:(OGYEB),V+!M00(10IA.(J&Z@@7[@!QU;<
MW:*GJI@U3(NY+?%IW!*6';4'.L):;MQQ,'G6+!7U1XHRI$T4T7ITN9-!R<]:
M)B//0*TIJ<?2O@J.3F=A&2+*D<,6W8J%P1Y+QB7,N1W;BZY$9;IE6!SZI%HH
M(*+M#(J5`Y:AP&OAJ$@-:^"JWHGX+KHMD57#A0B*""1UEEE3`1)))(ICJ**'
M,(`0B9"B(B/``U!25?\`WV7U:>0<W?$[+FV5QQC"U8J*6DXM3U4>9^BL\47;
MHN4P%)<R`*`!Q*(@`C35]@(;JK;C4J5;9UD6S[NPE8<#"SD>[N*U[99LKC@4
MW!1E(==)95(/6-3<JI$E>`D/02&`>`UU;>"#53;2GQ3IW;5L^:N63UNB\9O&
MZS5VT<I$7;.FSA,R*[=PBJ!DUD%DCB4Y3`)3%$0'AJC'OB>V6,ELC2""#0@C
MH0>H(/2BC)''-&Z*5H=$X$.!`(((H00=""-"%5$[B'9,O^V[QELY;)(M>6@7
M3XUQ26(HAZ9E==H3`+'>KO\`'BQW"!Y*-]3RG;LD3^L;']U(#D`.7<WM=[@,
M;=V+./<_>([IK=@N7BL<K.E)]#M=30N(V.'6AK7SP[T^U;,6.3DY;VKC,EFY
MQE=9L=MFA?7=6WU&]M:;6`[V'Z:@"C<\-]Y[??M?3#'.;K*^J3>V1+&BTRA#
M3-J7['`SZ;;T#ZYVK03/BH)HB7G=-%G`G$1.J8>&NTYWL/VXY@?U3`7'V;YO
MFK;N;)"XG7<(R=*UZ,<&TT#0ND<9]T'=[M^W]$Y7:C(1VYV4NVOAN&[:#:90
M*NH!3YV.<>I<4YEW^T"[CLA)H6WB#:!$HW?*+$:Q2OS!=5_`HX6`2()I0L?:
MENF<'%00&GJ0K2G#QUU)GMGXMC";K.9QYL6`EWR1P]/YW2/I_P!E=[D]Y/.,
MTP67&N-0C(R&C#ZLMQ4GH!&V&,G7^9.8VI;5>X#NJS?CS='O[OB;L6S\97&U
MO/'."6A4H$%Y]F)U8MV]M!B91I!1K%14]32)EY90!Y"F*01-KJ7-.9=M.&\?
MNN']M;>.XOKN(Q3W9J^C#HX"4T+R?)E(QUU(HN_=N^WW>/N#RNSY]WANI;7&
M6,XGMK``1_U&ZL)A;I&UIKK+68CY00TDIR_><V8WENSVY0\KBR(4G\GX?N!:
MZH>W6A2`_N>`>L%65PPT>)S%%>2*D!'#9$.*RB?*'$0KU/L/SRQX7RF2#,2"
M/$WT8C<\](W@U8X_RUJ''P!JN]>Y_MAD^XO"8Y\!&9L[C9C*V,`;I8RTB1C?
M-WTN:T:N((!J5"/L`[L%R;!L92VW;+.![MN6-A;KFY6$4:*JV]<\+(RIT_B<
M!*1LTS*BX;IO6XG3,0Y#I\QB\IN`AL%W+[,6G<K+LY1A<C#%+)"QK]P#XW!O
MTO:YAT-#2E*'34+5+LW[B,AV>P,G"N1XBXG@BN)'QEI].5CG4WQO;(-1N%00
M014BAT2WYRRUN\[KN-[_`+F>X^D-O6S/#MKS^1G@N@>.)/)MSVQ'+N(B(^*.
M6T>$JH5<0/TT$!:LQ#F.H<QBTZ[QW"<'[,Y6UM([IN3YU?3,@;2@;!'(X!SM
MH)VZ:5)W.Z```KMG+>2=R/<-@[V^FLGX;MCC+:2X=6KG7,L326,WD-#S76C6
MED?4N)(I&QVD<WXVV^[V\?9#R],L[7LM2VKQMIS<DL1<D7!2-QQB3:/D7ZY$
M50:M$U4A(=8X`1,#U$P:ROWLX]EN3]O[G&X2-TU^)8I!&T@N>UCJN#145--:
M#4T6#O;ARO`\*[I6N7Y)*VWQACEB,KJ[(W2,+6N<16@KH2=!6JNR[B,\X8Q=
M@ZY+XR-D&V[<L^Y[*G2V_)O)1N@%T?$[:=.F+.VZB8TH^DFJQ3($2*<QN<!I
M36@'%N.9[,<BBQ^+M99;Z&X9O:&D^GMD`)D_PM:1J2?->I_-N7\6X_Q*?+9N
M]@@QEQ:R>FYSP/5WQ$M;%_B<X$;0`:U"I2]JK,..\-;^;`OZ_P";0M"Q7OSO
M"!/SZI6C"(^9&BZ<0K-/E`*@T1`0*154PE(4X\1"NM_.\F"RF>[;7.-QL9GR
M+?2=L9JYVP@NV@:GX#JO++V\\GP?%N[]IE\S,VVQ3S-'ZDAHUGJ,<&E[N@'0
M%QH*J^K`ST+=$/&W#;DJPG(*8:(OXJ7BW*3V/D63@O,BZ:.D#'1705+Q`Q1$
M!UYO7-M<6EP^UNV.CN(W$.:X4((Z@@Z@A>OMG>6N0M67MC(R6TE:',>PAS7-
M/0M(T(/FFJ[X]HMH[T\`7-A^XU4(N9,)9RP[I40ZJEKWE'I*A%R`\@=<T>N*
M@HNTR"'40./`1``UW/MYS:]X#R6'.6H+[?Z)HZT]2(D;AY;AU:3T(_%8^[L=
MM\=W1X=/QJ](CN_KMY2*^E,T':[SVFI:\#JTGQ`5+%2T-]?:MSF6XVT)<^/+
ME:&<1Z,^UCEI[&V1[?2<@=1LNX0(K%3L$Z,D!^F<R;AN8:@*2@"(;\B][=]Y
M..FU=)#=6KJ.V%P9/`\C0@'YF/%>NK3\0O+4XSNW[>N6??1Q7%E>-):)`WU+
M:XC!U!(^21CJ#0D.'\KAI*K9'[1O?+2&;L\@;986;N%%(J;B6M:]9"%8R"X<
M#'"%?V_)J1X<P\"@Z7UAK(^UG&NN'28S+R16I.C9(@\M'EO:]N[\=H6PF(][
MV7CM6Q9K`PRW@&KXIW,:X^?INC?M_#>Y>E7?SW+^Y4NZQ%M?PX3!-DSI1C+P
MR&V6E'*L'#NJH/%7609:/AFT055HJ-4F+07R@A1$X#J#>VW:?M.UN<Y??'(Y
M"/YHH"&C>X=*0M<XNH1U>[8/X@KSN\'?7OG([CG`\8,3B9ODFN&E[BQAT<3<
MO:QK`6GI&TR'HTU4]?ZJJGZD?ZH_SH[]?]'OIU\^47]5\=]!S?,%>IZS_3/X
MO/S=?E]ZO/K7']YC_<+][^@/3^_]?T=*;-WT>7T:?X:_!;>_[>O_`-J?]M_N
MG>O^F?;?<:U]3;_XGG]?S5^JFO5:YW!L@N;,P4K!L3'2=9"FF]KF7+S`4D<5
M!:2E$SF`/=]2S:"F'$/O?FUTB,`NU62W&@6D]N+&(6]C><R._:].2OF1]+&*
M'3Y52V[$T*D9,_FW?/C&.`>-4]5E=5U%1@TJI']6E-&B(T1&B*-#>IM`E<CO
M5,J8P9).KK*U(A=%LI@FFM<*+<HE0DHX1$J:DJ@D/(HF;BN0`H(F``&ZQW@>
MBBX>(3;<"[U;VP21#&N6[>EY>W88PQ[,CA+T%UVTFB;D%D*;X$B2;)N:M"&,
M50@<"F,%`U,Q[]12JCNVZ%/@-N?V87N4DU<#JS'4@J0H*#=MCI+2R="A^&H>
M1AUUCE3\`$IC%&G`::AZ<GQ4MS4HL!N@VU-F:,?;EZ6XP8)!1!E%QJS!FD`T
MKTFS=DBBF'#R*&ABD\0FYJ]!,B[9I591SRV&\<.3F6675M=BHLNJH(F.JJJI
M&"=0YS#43"(B(^.HEDC>M4JTK98BZL%-'2;^$;V<P>I5Z+R/MYDR=I@8*&Z;
MANP26)S!P&@A75*.^*5`6[_/=E/T3H&E&;I!<ADE4%$3JI*I'+RG34242$AT
MSD&@@("`AIM=Y%5W!8).&P\IP3M6R!X>5K0X</(/]'APIH=P%36B?*L_#M+"
MA5E',##V]#N%TP05<14,QCEED0,"A45%6C5$YTN?B!1$0KQ\=4^8IHME"38'
M^ZX*/Y.;_!JBK5=H/6IAX*U\/(?/\VA;I4A%KMQ6=8UY)D2NZU+6NI-,O(FG
M<=OQ4V1,@FYN0A)-FZ*4HF&M```KKZ[7(7]B:V,\T)/^![F?\)"X^^Q6*RC0
MW)6UO<,'02QLD%/\X*[[?M&S;23,C:MKVU;*1RE(9*WX.,ADS$)]PAB1S5L4
MQ2^0"%`U2ZOKZ]=NO9I9G5K5[W.U_P`Q*E98S&XYI;C[>"!I\(XV,'_=`6RA
M00X#4/;4=?)0+[ES3]W][5?@BU&<Q]85SNTG]RV1:-Q/FYDSH/9VVH:6=H'2
M`02,BY?LG"R9DJ^Z(&`2^6ONM\GDK-ABM+B>*,]0R1[0:^8!`7&W>&P^0D$U
M_:6T\K:4=)$QY%.E"YI(IX+/+Q$2ZC%(5S&1[B&6:BQ6B%V39:,59&)TS,U6
M"B1FJC4R?NBF)!()>%*:^9L\[)A<->\7`-=P)W5\Z]:_'JOL?;6\EN;62-CK
M4MVEA:"PMZ;2TBE/A2B3)3;Y@19([=;"&(54%4S)*HJ8ULPZ2B1P$IDSIFA1
M(=,Q1H("%!#7+MY/R5K@YN1O@X>(GEK_`,:X!W"^'.:6.Q.,+"*$&U@H1Y4V
M+:9G&V.KCC(B$N&P;+GH:WR$2@8F:M:"E(R$23;E:)IQ#!\P7:QJ:;4@)%!$
MA`!,`*'`*:^*WRN4M)I+BUN;B.XE/SN;(]KGZU^8@@NUUUKKKU7(76"PE]!'
M:WMG:S6L(I&Q\4;VQ@"@#&N:0T4T^4#33HM9^@."!_\`93$G_P`<6=_V-KZ_
MW)R+_P"?>_\`KR_ZE\'[-XAT_2L;_P#6A_T)28B&B+?C6<-`Q<="0\>B#>/B
M8ADVC8QBW*(F*@S8,TD6K5$#&$0*0I2U$>&N*GGFN977%R]TD[S5SG$N<3YD
MFI/]JYVVM;:R@;:V<;(K5@HUC&AK6CR:UH``^`"R6K2OK'R<3%S3%>,F8UA+
MQKDH%<Q\FS;OV3@H#4"KM7::J"I0$/`Q1U<AFFMY!+;O<R4='-):1^!%"%9N
M+>WNXC!=1LD@=U:YH<T_B"""DX+@;!I%`6)AG%!5BGZA52X[M`JA5`-S`<#A
M#@8#\W&M:UURW[DY$1M-_>[?_/E_U+@QP_B0=O&+QP?6M?MH:U_'8E-9LF<>
MV19,&C9BS;D!-NT9H)-6R"8>!$4$"$22('L*`!KB))))7&25Q=(>I)J3^)*Y
MZ.*.%@BA:UD3>@:``!Y`#0!>JFK=-**XDDS-]'?E$/K9\M_*7Q!MTOF6O0^)
M5'T_I.E_._44K7I<>2O-[M=2%:_+U5#3Q6]VI\M?+<)\G?"_E;X:V^`_!>C\
M+^&],/3^CZ'X?2Y?9QK6O&NAK77JJCX+8-41&B(T1&B(T1(IECZ!=`_U@^G?
M-T2?]Y_A/Q?T_O<GIN?_`#QTO&G2X:DW=_"J&GBF8N?[,?U"W7^0^MS_`(G3
M^H')S<*<O0_!Y?9R\-3_`*OQ4?D6?A_[.>A?@_R73^)T_GS^#JZK_6^*?(E,
MCOU,J%^'?+-*!R\GS9X<*4ZFJ?U?&J?(M[8?JVT#T'P2G"G)\?\`LI]_5/ZB
MK\JVUI]&O=])\,\/=Y?BWAP_E_9JAW^-4&WP6?;_`$YK_-_15IY>O\/]]J)K
MXUHJZ++I?)_#I>F\0I3U7CY4KIK\>G_0JZ+))?`>'2Z7V4Z_L^W[-45#3Q7I
M)\*K[G3KP_QGCY>.JZ_V*J]9?2\.7E\>'WO;]OVZHB[/P?\`:Z(NPO+3W?#1
:%]:(C1$:(C1$:(C1$:(C1$:(C1$:(C1%_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
